Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 19c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.39), $0.19 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• JPMorgan Starts BlossomHill Therapeutics (BLSM) at Overweight
• Z AI Co Ltd (2513:HK) PT Raised to HK$1,500 at Bernstein SocGen Group